BioCryst Pharmaceuticals Inc

The current institutional shareholding score of BioCryst Pharmaceuticals Inc is 10.00, ranking 1 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 92.73%, representing a quarter-over-quarter decrease of 10.51%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.31% of shares outstanding, with 1.41% increase in holdings.